Namuyinga Ruth J, Mwandama Dyson, Moyo Dubulao, Gumbo Austin, Troell Peter, Kobayashi Miwako, Shah Monica, Bauleni Andrew, Vanden Eng Jodi, Rowe Alexander K, Mathanga Don P, Steinhardt Laura C
Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Malaria Alert Centre, College of Medicine, University of Malawi, Blantyre, Malawi.
Malar J. 2017 Jan 23;16(1):40. doi: 10.1186/s12936-017-1693-3.
Appropriate diagnosis and treatment are essential for reducing malaria mortality. A cross-sectional outpatient health facility (HF) survey was conducted in southern Malawi from January to March 2015 to determine appropriate malaria testing and treatment practices four years after implementation of a policy requiring diagnostic confirmation before treatment.
Enrolled patients were interviewed, examined and had their health booklet reviewed. Health workers (HWs) were asked about training, supervision and access to the 2013 national malaria treatment guidelines. HFs were assessed for malaria diagnostic and treatment capacity. Weighted descriptive analyses and logistic regression of patient, HW and HF characteristics related to testing and treatment were performed.
An evaluation of 105 HFs, and interviews of 150 HWs and 2342 patients was completed. Of 1427 suspect uncomplicated malaria patients seen at HFs with testing available, 1072 (75.7%) were tested, and 547 (53.2%) tested positive. Testing was more likely if patients spontaneously reported fever (odds ratio (OR) 2.6; 95% confidence interval (CI) 1.7-4.0), headache (OR 1.5; 95% CI 1.1-2.1) or vomiting (OR 2.0; 95% CI 1.0-4.0) to HWs and less likely if they reported skin problems (OR 0.4; 95% CI 0.2-0.6). Altogether, 511 (92.7%) confirmed cases and 98 (60.3%) of 178 presumed uncomplicated malaria patients (at HFs without testing) were appropriately treated, while 500 (96.6%) of 525 patients with negative tests did not receive anti-malarials. Only eight (5.7%) suspect severe malaria patients received appropriate pre-referral treatment. Appropriate treatment was more likely for presumed uncomplicated malaria patients (at HFs without testing) with elevated temperature (OR 1.5/1 °C increase; 95% CI 1.1-1.9), who reported fever to HWs (OR 5.7; 95% CI 1.9-17.6), were seen by HWs with additional supervision visits in the previous 6 months (OR 1.2/additional visit; 95% CI 1.0-1.4), or were seen by older HWs (OR 1.1/year of age; 95% CI 1.0-1.1).
Correct testing and treatment practices were reasonably good for uncomplicated malaria when testing was available. Pre-referral treatment for suspect severe malaria was unacceptably rare. Encouraging HWs to elicit and appropriately respond to patient symptoms may improve practices.
恰当的诊断和治疗对于降低疟疾死亡率至关重要。2015年1月至3月在马拉维南部开展了一项横断面门诊卫生机构(HF)调查,以确定在实施治疗前需确诊的政策四年后,疟疾检测和治疗的恰当做法。
对登记患者进行访谈、检查并查阅其健康手册。询问卫生工作者(HWs)有关培训、监督以及获取2013年国家疟疾治疗指南的情况。对卫生机构的疟疾诊断和治疗能力进行评估。对与检测和治疗相关的患者、卫生工作者及卫生机构特征进行加权描述性分析和逻辑回归分析。
完成了对105个卫生机构的评估,以及对150名卫生工作者和2342名患者的访谈。在有检测条件的卫生机构中,1427例疑似非重症疟疾患者中,1072例(75.7%)接受了检测,547例(53.2%)检测呈阳性。如果患者自发向卫生工作者报告发热(比值比(OR)2.6;95%置信区间(CI)1.7 - 4.0)、头痛(OR 1.5;95% CI 1.1 - 2.1)或呕吐(OR 2.0;95% CI 1.0 - 4.0),则更有可能接受检测;如果报告有皮肤问题,则接受检测的可能性较小(OR 0.4;95% CI 0.2 - 0.6)。总共,511例(92.7%)确诊病例以及178例疑似非重症疟疾患者(在无检测条件的卫生机构中)中的98例(60.3%)得到了恰当治疗,而525例检测结果为阴性的患者中有500例(96.6%)未接受抗疟药治疗。只有8例(5.7%)疑似重症疟疾患者接受了恰当的转诊前治疗。对于疑似非重症疟疾患者(在无检测条件的卫生机构中),体温升高(每升高1°C,OR 1.5;95% CI 1.1 - 1.9)、向卫生工作者报告发热(OR 5.7;95% CI 1.9 - 17.6)、在过去6个月中接受过额外监督访视的卫生工作者诊治(每增加一次访视,OR 1.2;95% CI 1.0 - 1.4)或由年长的卫生工作者诊治(每年长一岁,OR 1.1;95% CI 1.0 - 1.1),更有可能得到恰当治疗。
当有检测条件时,非重症疟疾的正确检测和治疗做法相当不错。疑似重症疟疾的转诊前治疗少得令人无法接受。鼓励卫生工作者询问并恰当应对患者症状可能会改善治疗做法。